Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04398524
Title A Phase II Study of Cemiplimab and ISA101b in Patients With Recurrent/Metastatic HPV16 Positive OPC
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors ISA Pharmaceuticals
Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | DEU | BEL

Facility Status City State Zip Country Details
City of Hope National Medical Center Recruiting Duarte California 91010 United States Details
UCSF Helen Diller Family Comprehensive Cancer Center Recruiting San Francisco California 94115 United States Details
Anschutz Cancer Pavilion Recruiting Aurora Colorado 80045 United States Details
H. Lee Moffitt Cancer Center & Research Institute Recruiting Tampa Florida 33612 United States Details
Beth Israel Deaconess Medical Center Recruiting Boston Massachusetts 02215 United States Details
Washington University Recruiting Saint Louis Missouri 63110 United States Details
Roswell Park Cancer Institute Recruiting Buffalo New York 14263 United States Details
Providence Portland Medical Center Recruiting Portland Oregon 97213 United States Details
The University of Texas M. D. Anderson Cancer Center Recruiting Houston Texas 77030 United States Details
University Hospital Antwerp Recruiting Antwerp Belgium Details
University Hospital Ghent Recruiting Ghent Belgium Details
Centre Hospitalier Universitaire de Liege Recruiting Liège 4000 Belgium Details
Clinic of Oncology Recruiting Olomouc Czechia Details
Institute of Radiation Oncology Recruiting Prague Czechia Details
University Hospital Motol, Clinic of Oncology Recruiting Prague Czechia Details
Saint Andre Hospital, Department of Oncology Recruiting Bordeaux 33000 France Details
Leon Berard Center, Department of Medical Oncology Recruiting Lyon 69008 France Details
CHU La Timone - La Timone Children's Hospital Recruiting Marseille France Details
Georges Pompidou European Hospital Enrolling by invitation Paris France Details
Jean Godinot Institute, Cancer Research Center Recruiting Reims France Details
Jean Godinot Institute Recruiting Reims France Details
Paul Strauss Center Recruiting Strasbourg France Details
Gustave Roussy Institute Recruiting Villejuif France Details
University Hospital Cologne, Department of Otorhinolaryngology (ENT) Recruiting Cologne 50937 Germany Details
Nordwest Hospital GmbH, Clinic of Hematology and Oncology Recruiting Frankfurt am Main 60488 Germany Details
University Hospital Giessen and Marburg GmbH Recruiting Gießen Germany Details
Universitätsmedizin Göttingen Recruiting Göttingen Germany Details
University Hospital Mannheim Recruiting Mannheim Germany Details
Caritas Klinikum Recruiting Saarbruecken Germany Details
University Hospital Ulm Recruiting Ulm Germany Details
Hadassah Medical Center Recruiting Jerusalem Israel Details
The Tel Aviv Sourasky Medical Cente Recruiting Tel Aviv Israel Details
Sheba Medical Center Recruiting Tel HaShomer Israel Details
European Institute of Oncology (IEO), IRCCS, Department of Otolaryngology and Facial Cervix Surgery Recruiting Milan Italy Details
Fondazione IRCCS Istituto Nazionale dei Tumori Recruiting Milan Italy Details
Institute of Cancer Research and Treatment of Candiolo Recruiting Turin 10060 Italy Details
Hospital Clinic of Barcelona Recruiting Barcelona Spain Details
University Hospital Vall d'Hebron Recruiting Barcelona Spain Details
Catalan Institute of Oncology, Hospital Duran i Reynals, Department of Oncology Recruiting Hospitalet de Llobregat 08908 Spain Details
University Clinic of Navarra - Madrid Recruiting Madrid 28027 Spain Details
University Clinic of Navarra Recruiting Pamplona 31008 Spain Details
Guy's Hospital Recruiting London United Kingdom Details
Royal Marsden Hospital Recruiting London United Kingdom Details
Royal Marsden Hospital - Sutton Recruiting Sutton United Kingdom Details
*Shaded cells indicate that there was no data available from for the field